LIFEVANTAGE CORP Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIFEVANTAGE CORP stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $133.00K, a 1109.09% increase year-over-year.
- LIFEVANTAGE CORP stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $2.00K, a 75.00% decline year-over-year.
- LIFEVANTAGE CORP stock issued during period, value, stock options exercised for the quarter ending 2020-12-31 was $991.00K, a 1735.19% increase year-over-year.
- LIFEVANTAGE CORP stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $11.00K, a 0.00% change year-over-year.
- LIFEVANTAGE CORP stock issued during period, value, stock options exercised for fiscal 2022 was $133.00K, a 90.36% decline from fiscal 2021.
- LIFEVANTAGE CORP stock issued during period, value, stock options exercised for fiscal 2021 was $1.38M, a 1714.47% increase from fiscal 2020.
- LIFEVANTAGE CORP stock issued during period, value, stock options exercised for fiscal 2020 was $76.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-06-30 | $133.00K 10-K · filed 2023-08-28 | |
| 2021-09-30 | $133.00K 10-Q · filed 2023-05-04 | |
| 2021-06-30 | $1.38M 10-K · filed 2022-08-23 | |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-03 | |
| 2020-12-31 | $991.00K 10-Q · filed 2022-05-03 | |
| 2020-09-30 | $11.00K 10-Q · filed 2022-05-03 | |
| 2020-06-30 | $76.00K 10-K · filed 2022-08-23 | |
| 2020-03-31 | $8.00K 10-Q · filed 2021-04-29 | |
| 2019-12-31 | $54.00K 10-Q · filed 2021-04-29 | |
| 2019-09-30 | $11.00K 10-Q · filed 2021-04-29 | |
| 2019-03-31 | $381.00K 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $12.00K 10-Q · filed 2019-05-01 | |
| 2018-09-30 | $172.00K 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |